Conversely, a study by Watanabe et al. in the Japanese population reported that ficolin-2 levels were significantly reduced in SLE patients in comparison to HCs, with no associations with clinical manifestations and laboratory parameters. This evidence concerns the gene FCN2 and systemic lupus erythematosus.